CBLI - Cleveland BioLabs, Inc.
| Previous Close | 1.7900 |
| Open | 1.7700 |
| Bid | 1.2700 x 900 |
| Ask | 0.0000 x 800 |
| Day's Range | 1.7200 - 1.8700 |
| 52 Week Range | 0.5000 - 5.0000 |
| Volume | 76,212 |
| Avg. Volume | 1,102,811 |
| Market Cap | 20.337M |
| Beta (5Y Monthly) | 0.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2100 |
| Earnings Date | Aug 13, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Benzinga
The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) 10X Genomics Inc (NASDAQ: TXG ) Achillion Pharmaceuticals, ...
- Simply Wall St.
What Kind Of Investor Owns Most Of Cleveland BioLabs, Inc. (NASDAQ:CBLI)?
A look at the shareholders of Cleveland BioLabs, Inc. (NASDAQ:CBLI) can tell us which group is most powerful...
- ACCESSWIRE
Cleveland BioLabs Reports Third Quarter 2019 Financial Results and Development Progress
BUFFALO, NY / ACCESSWIRE / November 14, 2019 / Cleveland BioLabs, Inc. (NASDAQ:CBLI) today reported financial results and development progress for the third quarter ended September 30, 2019. Cleveland ...
- Simply Wall St.
Here's Why We're Watching Cleveland BioLabs's (NASDAQ:CBLI) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Simply Wall St.
Some Cleveland BioLabs (NASDAQ:CBLI) Shareholders Have Taken A Painful 83% Share Price Drop
We're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't...
- ACCESSWIRE
Cleveland BioLabs Reports Second Quarter 2019 Financial Results and Development Progress
BUFFALO, NY / ACCESSWIRE / August 14, 2019 / Cleveland BioLabs, Inc. (NASDAQ:CBLI) today reported financial results and development progress for the second quarter ended June 30, 2019. Cleveland BioLabs ...
- Simply Wall St.
Is Cleveland BioLabs, Inc. (NASDAQ:CBLI) Overpaying Its CEO?
Yakov Kogan has been the CEO of Cleveland BioLabs, Inc. (NASDAQ:CBLI) since 2012. First, this article will compare CEO...
- ACCESSWIRE
Cleveland Biolabs Reports First Quarter 2019 Financial Results and Development Progress
BUFFALO, NY / ACCESSWIRE / May 15, 2019 / Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the first quarter ended March 31, 2019. Cleveland BioLabs ...
